July 3, 2023, 1 p.m. | Kristin Houser

Freethink www.freethink.com

AI-driven drug development has led to the launch of phase 2 trials of a drug to treat idiopathic pulmonary fibrosis (IPF).

ai development disease drug development health launch medicine

Lead Developer (AI)

@ Cere Network | San Francisco, US

Research Engineer

@ Allora Labs | Remote

Ecosystem Manager

@ Allora Labs | Remote

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US

AI Research Scientist

@ Vara | Berlin, Germany and Remote